Home »
Academic Articles & Research Papers
Showing 9 of 9 academic articles
Zhang R, Chen X, Li N, Peng M • BMC cancer
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1186/s12885-026-16534-w
PMC: PMC13732848
Feng D, Yan H, Ni Q, Peng Z et al. • Oncology research
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.32604/or.2026.087712
PMC: PMC13732338
Shi Y, Yang J, Cai F, Huang J et al. • The Journal of international medical research
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1177/03000605261488089
PMC: PMC13735068
Jangir K, Kumar N, Saini C, Vats P et al. • Frontiers in oncology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fonc.2026.1956981
PMC: PMC13572222
Shuping Wang, Pengcheng Chen, Xiaozhen Jing, Jinglin Zou et al. • Materials & Design
(2026)
STING agonist-based immunotherapy holds considerable promise for cancer treatment, yet its efficacy against immunologically “cold” tumors such as lung adenocarcinoma (LUAD) remains markedly limited. A major obstacle lies in the highly glyco...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.matdes.2026.117182
Yan Dora Zhang, Amber N. Hurson, Haoyu Zhang, Parichoy Pal Choudhury et al. • Nature Communications
(2020)
In cancer many gene variants may contribute to disease etiology, but the impact of a given gene variant may have varied effect size. Here, the authors analyse summary statistics of genome-wide association studies from fourteen cancers, and ...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41467-020-16483-3
Lingling Tang, Jinjin Liu, Linyun Zhu, Qingge Chen et al. • Frontiers in Pharmacology
(2018)
Lung squamous cell carcinoma (LSCC) is a common histological lung cancer subtype, but unlike lung adenocarcinoma, limited therapeutic options are available for treatment. Curcumin, a natural compound, may have anticancer effects in various ...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fphar.2018.00060
Joshua George Thomas, Mohammed Ayyub, Lovely M. Annamma, Prathibha Prasad et al. • Biomedicines
(2026)
Background: Epithelial-derived carcinomas exhibit genomic instability due to genetic mutation and epigenetic dysregulation. Mechanisms such as DNA methylation, histone modifications, and noncoding RNA regulation may lead to tumor progressio...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/biomedicines14102234
Wu L, Shang H, Mao C, Wei Z et al. • Technology in cancer research & treatment
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1177/15330338261494765
PMC: PMC13735647